drugset / Trial / NCT00467584
Aspirin for Treatment of Multiple Sclerosis-Related Fatigue
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine whether aspirin is effective for treatment of fatigue caused by multiple sclerosis (MS).
Timeline
- Start
- 2007-07
- Primary completion
- 2013-09
- Completion
- 2013-09
Outcome
Outcome not reported
Stopped (Enrollment): “Interim analysis indicated treatment unlikely effective;slow recruitment”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aspirin | Small molecule | 162 mg | Oral |
| Comparator | Aspirin | Small molecule | 1300 mg | Oral |